NCT00309088View on ClinicalTrials.gov

FK506 Phase 3 Study: a Study for Steroid Non-resistant Myasthenia Gravis (MG) Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

April 30, 2006

Primary Completion Date

June 30, 2008

Study Completion Date

June 30, 2008

Conditions
Myasthenia Gravis
Interventions
DRUG

tacrolimus

oral

DRUG

placebo

oral

Trial Locations (9)

Unknown

Chubu Region

Chugoku Region

Hokkaido Region

Hokuriku Region

Kansai Region

Kanto Region

Kyushu Region

Shikoku Region

Tohoku Region

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY